Niacin/lovastatin

Niacin/lovastatin

Combination of
Niacin	n/a
Lovastatin	Statin
[[{{{component3}}}]]	? Class
[[{{{component4}}}]]	? Class
[[{{{component5}}}]]	? Class
Clinical data
Pregnancy category	US: X (Contraindicated)
Routes of administration	Oral
ATC code	C10BA01 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Niacin/lovastatin (tradename Advicor) is a drug combination used for the treatment of dyslipidemia. It is a combination of niacin and the statin drug lovastatin (best known as Mevacor in the U.S.). The combination preparation is marketed by Abbott Laboratories

It was approved by the FDA on December 17, 2001.

Dosage

The combination is available as tablets containing:.

• 500 mg/20 mg
• 750 mg/20 mg
• 1000 mg/20 mg
• 1000 mg/40 mg

External links

• Advicor website

Template:WikiDoc Sources